Urol. praxi. 2023;24(1):6-13 | DOI: 10.36290/uro.2023.011

Urinary incontinence - medication versus surgery

MUDr. Miroslava Ryšánková1, MUDr. Marie Hurtová1, 2
1 Urologie Náchod, s. r. o., Náchod
2 Urologická klinika Fakultní nemocnice Hradec Králové

Urinary incontinence is a growing problem in current urological medicine. It affects the patient in his socioeconomic and emotional life, burdening the environment especially economically. The authors of the article have set themselves the goal of summarizing the current possibilities of its treatment, especially by medication and surgery. It is important to determine the type of incontinence for self-treatment. The most common type of incontinence in both genders is stress and urgency incontinence. Other types are represented to a lesser extent and sometimes stand outside the current official recommendations of professional societies. The treatment itself then depends on the type of incontinence itself. In some places, more treatment with medicinal products is used, in others, surgical treatment. It is often necessary to combine the treatments.

Keywords: urinary leakage, incontinence, surgical treatment of incontinence, medical treatment of incontinence.

Accepted: March 16, 2023; Published: March 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšánková M, Hurtová M. Urinary incontinence - medication versus surgery. Urol. praxi. 2023;24(1):6-13. doi: 10.36290/uro.2023.011.
Download citation

References

  1. Harding CK, Lapitan MC, Arlandis S, Bø K, et al. EAU Guidelines on Management of Non-Neurogenic Female Lower Urinary Tract Symptoms. European Association of Urology 2022, limited update March 2022.
  2. Gravas S, Cornu JN, Gacci M, Gratzke C. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology 2022, UPDATE MARCH 2022. Go to original source...
  3. Coyne KS, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104:352. Go to original source... Go to PubMed...
  4. Hunskaar S, et al. The prevalence of urinary incontinence in women in four European countries. BJU Int. 2004;93:324. Go to original source... Go to PubMed...
  5. Rovner ES. Urethral diverticula: a review and an update. Neurourol Urodyn. 2007;26:972. Go to original source...
  6. Shamliyan TA, et al. Male urinary incontinence: prevalence, risk factors, and preventive interventions. Rev Urol. 2009;11:145. Go to PubMed...
  7. Haglind E, et al. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial. Eur Urol. 2015;68:216. Go to original source... Go to PubMed...
  8. Chapple CR, Cardozo L, Nitti VW, et al. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn. 2014;33:17-30. Go to original source...
  9. El-Zawahry A. Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB). Curr Urol Rep. 2019; 20(6):33. Go to original source... Go to PubMed...
  10. Roehrborn CG, et al. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study. BJU Int. 2014;113:623. Go to original source... Go to PubMed...
  11. www.sukl.cz.
  12. Wang CJ, Lin YN, Huang SW, et al. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol. 2011;185:219-223. Go to original source... Go to PubMed...
  13. Zhang P, et al. Meta-analysis of female stress urinary incontinence treatments with adjustable single-incision minislings and transobturator tension-free vaginal tape surgeries. BMC Urol. 2015;15:64. Go to original source... Go to PubMed...
  14. Ženíšek J. Novinky v léčbě stresové inkontinence u mužů. Urol. praxi. 2014;15(2):68-71.
  15. Freites J, et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2019;12:CD002239. Go to original source...
  16. Siddiqui ZA, et al. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Int Urogynecol J. 2017;28:1275. Go to original source... Go to PubMed...
  17. Chapple C, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2013;64:249. Go to original source... Go to PubMed...
  18. Jairam R, et al. Predictive Factors in Sacral Neuromodulation: A Systematic Review. Urol Int. 2021;1:21.
  19. Tutolo M, et al. Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature. Eur Urol. 2018;73:406. Go to original source... Go to PubMed...
  20. Pané-Alemany R, et al. Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: Randomized controlled trial. Neurourol Urodyn. 2021;40:1761. Go to original source...
  21. Cartwright PC, et al. Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol. 1989;142:1050. Go to original source... Go to PubMed...
  22. Cohen AJ, et al. Comparative Outcomes and Perioperative Complications of Robotic Vs. Open Cystoplasty and Complex Reconstructions. Urology. 2016;97:172. Go to original source... Go to PubMed...
  23. Corcos J, et al. The use of vaginal lasers in the treatment of urinary incontinence and overactive bladder, systematic review. Int Urogynecol J. 2021;32:553. Go to original source... Go to PubMed...
  24. Krhovský M. Využití implantátů při řešení ženské inkontinence. Urol. praxi. 2019;20(5):207-213.
  25. Zachoval R, Krhut J. "Warning time" a jeho role v medikamentózní léčbě pacientů s hyperaktivním močovým měchýřem. Ces Urol. 2021;25(3):175-181. Go to original source...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.